ArticleClinical cancer research : an official journal of the American Association for Cancer Research2026
Avutometinib, Abemaciclib, and Fulvestrant in Patients with HR+/HER2- Metastatic Breast Cancer Previously Treated with CDK4/6 Inhibitor: A Single-Arm Phase I Trial.
Adrienne G Waks et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.